Literature DB >> 6732232

Treatment of experimental cutaneous leishmaniasis with liposome-intercalated amphotericin B.

C B Panosian, M Barza, F Szoka, D J Wyler.   

Abstract

The therapeutic efficacy of a liposomal preparation of amphotericin B was evaluated in two murine models of cutaneous leishmaniasis. No significant decrease in tissue parasite density was observed in C57BL/6 mice after systemic treatment instituted seven days after footpad inoculation with Leishmania tropica; in contrast, BALB/c mice showed a modest response.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6732232      PMCID： PMC185609          DOI： 10.1128/AAC.25.5.655

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  18 in total

1.  Antileishmanial activity of antimonials entrapped in liposomes.

Authors:  R R New; M L Chance; S C Thomas; W Peters
Journal:  Nature       Date:  1978-03-02       Impact factor: 49.962

2.  Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs.

Authors:  C R Alving; E A Steck; W L Chapman; V B Waits; L D Hendricks; G M Swartz; W L Hanson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

3.  The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis.

Authors:  C D Black; G J Watson; R J Ward
Journal:  Trans R Soc Trop Med Hyg       Date:  1977       Impact factor: 2.184

4.  Current concepts in parasitology. Leishmaniasis.

Authors:  P D Marsden
Journal:  N Engl J Med       Date:  1979-02-15       Impact factor: 91.245

Review 5.  The chemotherapy of protozoal infections of man.

Authors:  E A Steck
Journal:  J Protozool       Date:  1981-02

Review 6.  Strategies in the treatment of systemic fungal infections.

Authors:  G Medoff; G S Kobayashi
Journal:  N Engl J Med       Date:  1980-01-17       Impact factor: 91.245

Review 7.  Comparative properties and methods of preparation of lipid vesicles (liposomes).

Authors:  F Szoka; D Papahadjopoulos
Journal:  Annu Rev Biophys Bioeng       Date:  1980

8.  Cutaneous leishmaniasis--a case with persistent organisms after treatment in presence of normal immune response.

Authors:  F A Neva; D Wyler; T Nash
Journal:  Am J Trop Med Hyg       Date:  1979-05       Impact factor: 2.345

9.  Murine cutaneous leishmaniasis: disease patterns in intact and nude mice of various genotypes and examination of some differences between normal and infected macrophages.

Authors:  E Handman; R Ceredig; G F Mitchell
Journal:  Aust J Exp Biol Med Sci       Date:  1979-02

10.  Lipids of Leishmania promastigotes.

Authors:  D H Beach; G G Holz; G E Anekwe
Journal:  J Parasitol       Date:  1979-04       Impact factor: 1.276
View more
  11 in total

Review 1.  Formulation and biopharmaceutical issues in the development of drug delivery systems for antiparasitic drugs.

Authors:  O Kayser; C Olbrich; S L Croft; A F Kiderlen
Journal:  Parasitol Res       Date:  2002-12-11       Impact factor: 2.289

2.  Activity of liposomal amphotericin B against experimental cutaneous leishmaniasis.

Authors:  V Yardley; S L Croft
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

3.  Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome.

Authors:  J P Gangneux; A Sulahian; Y J Garin; R Farinotti; F Derouin
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

4.  Oral azithromycin versus its combination with miltefosine for the treatment of experimental Old World cutaneous leishmaniasis.

Authors:  Eglal I Amer; Maha M Eissa; Shereen F Mossallam
Journal:  J Parasit Dis       Date:  2014-08-31

Review 5.  Liposomes as carriers of antimicrobial agents.

Authors:  G Lopez-Berestein
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

6.  Efficacious topical treatment for murine cutaneous leishmaniasis with ethanolic formulations of amphotericin B.

Authors:  S Frankenburg; D Glick; S Klaus; Y Barenholz
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

7.  Antileishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeys.

Authors:  J D Berman; W L Hanson; W L Chapman; C R Alving; G Lopez-Berestein
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

8.  Monocyte subpopulations as important biomarkers of resistence and susceptibility during experimental infection with Leishmania (Leishmania) major.

Authors:  Tassiane Assiria Fontes Martins; Vitor Silva Barbosa; Gregório Guilherme Almeida; Lis Ribeiro Do Valle Antonelli; Wagner Luiz Tafuri; David M Mosser; Ricardo Gonçalves
Journal:  Biomed Pharmacother       Date:  2018-09-05       Impact factor: 6.529

9.  Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome-intercalated amphotericin B.

Authors:  F C Szoka; D Milholland; M Barza
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

10.  Discovery, Semisynthesis, Antiparasitic and Cytotoxic Evaluation of 14-Membered Resorcylic Acid Lactones and Their Derivatives.

Authors:  Xue-Qing Zhang; Carmenza Spadafora; Laura M Pineda; Michelle G Ng; Ji-Hong Sun; Wei Wang; Chang-Yun Wang; Yu-Cheng Gu; Chang-Lun Shao
Journal:  Sci Rep       Date:  2017-09-18       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.